Bidard, F., Gessain, G., Bachelot, T., Frechin, L., Vincent-Salomon, A., Drubay, D., Lemonnier, J., Walter, T., Penault-Llorca, F., Martin, A., Gaudin, C., Bichat, A., Sassi, F., Berlemont, S., Chavez-MacGregor, M., Rugo, H. S., Badoual, C., Pistilli, B., Ribeiro, J., Meglio, A. D., Lacroix-Triki, M., Luis, I. V., Lerousseau, M., André, F. (2025). Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02272